Search research articles
Contact Us
Filters
Showing results (131-140 of 149) with videos related to
Page
of 15
Sort By:
Breast Cancer (Tokyo, Japan)
|
January 22, 2013
Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology
Muhammet Ali Kaplan, Abdurrahman Isikdogan, Doğan Koca, et al.
JCO Global Oncology
|
March 19, 2026
Prevalence and Reactivation of Hepatitis B and C in Patients Undergoing Chemotherapy for Solid Tumors
Mustafa Gürbüz, Deniz Tural, Timuçin Çil, et al.
American Journal of Cancer Research
|
February 9, 2026
Second-line nab-paclitaxel and gemcitabine for advanced pancreatic cancer following FOLFIRINOX: outcomes and insights
Aysegul Merc Cetınkaya, Ali Murat Tatlı, Sabin Goktas Aydın, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 28, 2022
Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer
Yusuf Ilhan, Ali Murat Tatli, Fatih Teker, et al.
Oncology
|
July 21, 2012
Biological subtypes and survival outcomes in breast cancer patients with brain metastases (study of the Anatolian Society of Medical Oncology)
Muhammet Ali Kaplan, Abdurrahman Isikdogan, Doğan Koca, et al.
Cancers
|
January 25, 2025
Enhancing Treatment Decisions for Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations: A Reinforcement Learning Approach
Hakan Şat Bozcuk, Leyla Sert, Muhammet Ali Kaplan, et al.
Cancer Investigation
|
December 13, 2021
Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study
Ahmet Bilici, Mukremin Uysal, Serkan Menekse, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
October 25, 2020
Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey
Muhammet Bekir Hacioglu, Osman Kostek, Senem Karabulut, et al.
Balkan Medical Journal
|
January 24, 2020
Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial
Atakan Demir, Nil Molinas Mandel, Semra Paydas, et al.
Clinical Lung Cancer
|
August 14, 2025
Real-World Outcomes in BRAF-Mutant Non-small Cell Lung Cancer: A Multicenter Analysis From the Turkish Oncology Group
Tuğba Akın Telli, Ali Murat Tatlı, Özkan Alan, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 149) with videos related to
Sort By:
Page
of 15
Breast Cancer (Tokyo, Japan)
|
January 22, 2013
Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology
Muhammet Ali Kaplan, Abdurrahman Isikdogan, Doğan Koca, et al.
JCO Global Oncology
|
March 19, 2026
Prevalence and Reactivation of Hepatitis B and C in Patients Undergoing Chemotherapy for Solid Tumors
Mustafa Gürbüz, Deniz Tural, Timuçin Çil, et al.
American Journal of Cancer Research
|
February 9, 2026
Second-line nab-paclitaxel and gemcitabine for advanced pancreatic cancer following FOLFIRINOX: outcomes and insights
Aysegul Merc Cetınkaya, Ali Murat Tatlı, Sabin Goktas Aydın, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 28, 2022
Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer
Yusuf Ilhan, Ali Murat Tatli, Fatih Teker, et al.
Oncology
|
July 21, 2012
Biological subtypes and survival outcomes in breast cancer patients with brain metastases (study of the Anatolian Society of Medical Oncology)
Muhammet Ali Kaplan, Abdurrahman Isikdogan, Doğan Koca, et al.
Cancers
|
January 25, 2025
Enhancing Treatment Decisions for Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations: A Reinforcement Learning Approach
Hakan Şat Bozcuk, Leyla Sert, Muhammet Ali Kaplan, et al.
Cancer Investigation
|
December 13, 2021
Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study
Ahmet Bilici, Mukremin Uysal, Serkan Menekse, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
October 25, 2020
Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey
Muhammet Bekir Hacioglu, Osman Kostek, Senem Karabulut, et al.
Balkan Medical Journal
|
January 24, 2020
Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial
Atakan Demir, Nil Molinas Mandel, Semra Paydas, et al.
Clinical Lung Cancer
|
August 14, 2025
Real-World Outcomes in BRAF-Mutant Non-small Cell Lung Cancer: A Multicenter Analysis From the Turkish Oncology Group
Tuğba Akın Telli, Ali Murat Tatlı, Özkan Alan, et al.
Page
of 15